Market Guru Raamdeo Agrawal Sees India Shares as “Fairly Valued”

India grew 7.1% in the year ended March, and Raamdeo Agrawal (joint MD, Motilal Oswal) said India could achieve a decade of double-digit growth if Prime Minister Narendra Modi accelerates reforms. Commentary is bullish for India’s long-term growth outlook but conditional on policy acceleration; market impact is limited and primarily sentiment-driven.

Analysis

If policy implementation shifts from talk to delivery, expect an outsized multi-year re-rating driven by a capital-expenditure-led growth phase rather than consumption alone. Mechanically, a sustained 2–3 percentage-point increase in gross fixed capital formation as a share of GDP would plausibly add ~1.5–3.0 percentage points to annual real GDP growth over a 3-year horizon by unlocking capacity, raising corporate utilisation and compressing unit costs through scale.

Winners will be capital-goods and project-facing chains (engineering contractors, cement, steel, construction logistics) and domestic banks/NBFCs that finance capex; losers in the near term include wage-sensitive export services and import-heavy discretionary goods if localisation ramps. Second-order effects: stronger domestic capex will pull forward demand for commodities and freight, tightening global supply for select inputs and boosting regional miners/steelmakers while increasing pass-through risk to inflation.

Key catalysts and timeframes: headline policy moves (land/labour/tax incentives) and a supportive budget can materialize materially within 3–12 months and drive orderbooks in 12–36 months; durable RoE improvement is a 3–7 year story. Tail risks that would reverse the trade include a fiscal slippage or bond-market selloff that forces monetary tightening, an adverse election outcome that stalls reforms, or sharp currency depreciation triggered by global EM stress.

The consensus risk is binary optimism priced like a smooth transition; execution frictions (permitting, supply bottlenecks, skilled labour shortages) and narrowing market breadth are under-appreciated. If reform delivery disappoints, expect 20–30% downside in cyclical names; if delivery accelerates, India could outperform broad EM by 20–40% over 24–36 months — positioning should therefore be asymmetric and catalyst-weighted.

Key Decisions for Investors

• Overweight INDA (iShares MSCI India ETF) for 12–24 months — size at 3–5% of portfolio risk budget. Thesis: capture a country-level re-rate if reforms accelerate. Risk/Reward: downside ~-15% on a policy reversal; upside target +30–40% if capex cycle materializes; use a 15% stop or hedge with 6–12 month put protection if volatility spikes.
• Pair trade: Long LT.NS (Larsen & Toubro) / Short TCS.NS (Tata Consultancy Services) for 6–18 months. Rationale: express capex-led outperformance vs export services; expected relative return +20–30% if orderbooks recover. Risk: project execution delays or an IT rebound; size as a market-neutral 1–2% risk weight and monitor orderbook indicators monthly.
• Bank exposure: Buy ICICI Bank ADR (IBN) for 12–36 months — overweight private banks vs sovereign-linked lenders. Thesis: higher credit growth, improving NIMs and fee income during a capex cycle. Risk/Reward: target +35–50% upside, down -25–30% on systemic asset-quality shock; hedge tail with long-dated puts if sovereign spreads widen.
• Options hedge/levered asymmetric: Buy 12–24 month call options on INDA (or EPI) sized to 1–2% notional (purchase calls or call spreads to cap premium). Rationale: low-cost asymmetric exposure to the reform outcome with defined downside (premium). Use this to express a high-conviction view without lingering equity downside exposure; if premium cheapens after a clear policy catalyst, scale into delta exposure.